BIOMARKERS AND COMBINATION THERAPIES USING ONCOLYTIC VIRUS AND IMMUNOMODULATION
- Application ID: EP13706770
- Status: █ EXAMINATION IN PROGRESS
This patent has the IPC combination A61, C12, and G01 Potter Clarkson LLP is specialized in the combination A61, C12, and G01. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Zacco Denmark A/S, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB, Kilburn & Strode LLP and 75 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.